Viewing Study NCT02856893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-28 @ 6:34 PM
Study NCT ID: NCT02856893
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-31
First Post: 2016-07-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD9291 View
None Osimertinib View
None Gefitinib View
None NSCLC View
None liquid biopsy View
None ctDNA View